Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4899
Source ID: NCT01509755
Associated Drug: Placebo
Title: Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: placebo|DRUG: liraglutide|DRUG: glimepiride
Outcome Measures: Primary: HbA1c (glycosylated haemoglobin) | Secondary: Fasting plasma glucose|Fructosamine|7-point blood glucose profile|Adverse events
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 196
Study Type: INTERVENTIONAL
Study Designs: Allocation: |Intervention Model: |Masking: |Primary Purpose:
Start Date: 2000-10
Completion Date: 2001-10
Results First Posted:
Last Update Posted: 2017-01-24
Locations: Novo Nordisk Investigational Site, Hvidovre, 2650, Denmark|Novo Nordisk Investigational Site, Kolding, 6000, Denmark|Novo Nordisk Investigational Site, København, 2400, Denmark|Novo Nordisk Investigational Site, Køge, 4600, Denmark|Novo Nordisk Investigational Site, Thisted, 7700, Denmark|Novo Nordisk Investigational Site, Århus C, 8000, Denmark|Novo Nordisk Investigational Site, Bekkestua, 1357, Norway|Novo Nordisk Investigational Site, Elverum, 2408, Norway|Novo Nordisk Investigational Site, Harstad, 9480, Norway|Novo Nordisk Investigational Site, Oslo, 0370, Norway|Novo Nordisk Investigational Site, Grästorp, 467 22, Sweden|Novo Nordisk Investigational Site, Göteborg, 413 45, Sweden|Novo Nordisk Investigational Site, Lund, 221 85, Sweden|Novo Nordisk Investigational Site, Uppsala, 751 85, Sweden|Novo Nordisk Investigational Site, Örebro, 701 85, Sweden|Novo Nordisk Investigational Site, Ayrsh, KA2 0BE, United Kingdom|Novo Nordisk Investigational Site, Church Village, CF38 1AB, United Kingdom|Novo Nordisk Investigational Site, Edinburgh, EH16 4SA, United Kingdom|Novo Nordisk Investigational Site, Enfield, EN2 8JL, United Kingdom|Novo Nordisk Investigational Site, Hull, HU3 2JZ, United Kingdom|Novo Nordisk Investigational Site, Leicester, LE5 4PW, United Kingdom|Novo Nordisk Investigational Site, Liverpool, L7 8XP, United Kingdom|Novo Nordisk Investigational Site, Northampton, NN1 5BD, United Kingdom|Novo Nordisk Investigational Site, Nottingham, NG7 2UH, United Kingdom|Novo Nordisk Investigational Site, Oxford, OX2 6HE, United Kingdom|Novo Nordisk Investigational Site, Plymouth, PL8 8DQ, United Kingdom|Novo Nordisk Investigational Site, Rugby, CV22 5PX, United Kingdom|Novo Nordisk Investigational Site, Sheffield, S5 7AU, United Kingdom|Novo Nordisk Investigational Site, Worksop, S81 OBD, United Kingdom
URL: https://clinicaltrials.gov/show/NCT01509755

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress